Sutro Biopharma (STRO) Q1 2024 Earnings Report

741 Followers

STRO Q1 2024 EPS Results

Actual EPS-$9.50

Consensus EPS-$9.22

Beat/MissMissed by -$0.28

One Year Ago EPS-$8.50

Actual Revenue$13.01M

Expected Revenue$12.07M

Beat/MissBeat by +$935.00K

YoY Revenue Growth+2.64%

QuarterQ1 2024

Date05/13/2024

TimeAfter Close

Conference CallMonday, May 13, 2024

STRO Upcoming Earnings

Sutro Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-1.66 / -	-6.7	―
Aug 12, 2026	2026 (Q2)	-2.19 / -2.33	-1.4	-66.43% (-0.93)
May 14, 2026	2026 (Q1)	-2.74 / -2.94	-9.1	67.69% (+6.16)
Mar 23, 2026	2025 (Q4)	-8.16 / -5.29	-8.3	36.27% (+3.01)
Nov 06, 2025	2025 (Q3)	-3.94 / -6.70	-5.9	-13.56% (-0.80)
Aug 07, 2025	2025 (Q2)	-3.82 / -1.40	-5.9	76.27% (+4.50)
May 08, 2025	2025 (Q1)	-6.43 / -9.10	-9.5	4.21% (+0.40)
Mar 13, 2025	2024 (Q4)	-8.30 / -8.30	5.2	-259.62% (-13.50)
Nov 13, 2024	2024 (Q3)	-7.35 / -5.90	-8.1	27.16% (+2.20)
Aug 13, 2024	2024 (Q2)	-7.92 / -5.90	-6.4	7.81% (+0.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed